AU2023334828A1 - Composition for improving nicotinamide mononucleotide production - Google Patents

Composition for improving nicotinamide mononucleotide production Download PDF

Info

Publication number
AU2023334828A1
AU2023334828A1 AU2023334828A AU2023334828A AU2023334828A1 AU 2023334828 A1 AU2023334828 A1 AU 2023334828A1 AU 2023334828 A AU2023334828 A AU 2023334828A AU 2023334828 A AU2023334828 A AU 2023334828A AU 2023334828 A1 AU2023334828 A1 AU 2023334828A1
Authority
AU
Australia
Prior art keywords
composition
carbohydrate
nmn
composition according
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023334828A
Other languages
English (en)
Inventor
Seiichirou HIGASHI
Yoshiko Honme
Masashi Morifuji
Satoru Ozaki
Yoshie Saito
Jun Wakabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Holdings Co Ltd
Original Assignee
Meiji Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Holdings Co Ltd filed Critical Meiji Holdings Co Ltd
Publication of AU2023334828A1 publication Critical patent/AU2023334828A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2023334828A 2022-08-30 2023-08-29 Composition for improving nicotinamide mononucleotide production Pending AU2023334828A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022136945 2022-08-30
JP2022-136945 2022-08-30
PCT/JP2023/031257 WO2024048593A1 (ja) 2022-08-30 2023-08-29 ニコチンアミドモノヌクレオチド産生向上のための組成物

Publications (1)

Publication Number Publication Date
AU2023334828A1 true AU2023334828A1 (en) 2025-02-20

Family

ID=90099532

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023334828A Pending AU2023334828A1 (en) 2022-08-30 2023-08-29 Composition for improving nicotinamide mononucleotide production

Country Status (5)

Country Link
EP (1) EP4581942A1 (https=)
JP (1) JPWO2024048593A1 (https=)
CN (2) CN119768073A (https=)
AU (1) AU2023334828A1 (https=)
WO (1) WO2024048593A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015069860A1 (en) * 2013-11-06 2015-05-14 President And Fellows Of Harvard College Biological production of nad precursors and analogs
TW201713774A (zh) 2015-08-06 2017-04-16 Kohjin Life Sciences Co Ltd 含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
CA3114836A1 (en) 2018-10-18 2020-04-23 Hill's Pet Nutrition, Inc. Pet food compositions
KR20220080075A (ko) * 2019-10-11 2022-06-14 고쿠리츠 다이가꾸 호우진 시즈오까 다이가꾸 니코틴아미드 리보시드를 산생하는 유산균, 및 니코틴아미드 모노뉴클레오티드 및 니코틴아미드 리보시드를 산생하는 유산균
KR20230124883A (ko) * 2020-12-25 2023-08-28 가부시키가이샤 오사카소다 니코틴아미드 모노뉴클레오티드의 제조 방법
CN116396882A (zh) * 2022-07-26 2023-07-07 深圳大学 一种nrk生产菌、生产nrk的方法以及应用

Also Published As

Publication number Publication date
CN119768073A (zh) 2025-04-04
WO2024048593A1 (ja) 2024-03-07
JPWO2024048593A1 (https=) 2024-03-07
EP4581942A1 (en) 2025-07-09
CN120788227A (zh) 2025-10-17

Similar Documents

Publication Publication Date Title
JP6882931B2 (ja) プレバイオティック製剤および使用方法
EP2934189B1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
TWI337080B (en) Prebiotic compositions
JP4626752B2 (ja) 炭水化物および組成物の新規な使用
TW201438720A (zh) 增強學習及記憶力之膳食寡糖
US20250319140A1 (en) Composition
EP4581942A1 (en) Composition for improving nicotinamide mononucleotide production
US20250205291A1 (en) Methods and compositions for slowing diabetes development of reducing a risk of diabetes
WO2007010975A1 (ja) Ｄ－プシコースの血中ｄ－フラクトース濃度上昇抑制への使用
KR101952991B1 (ko) 맥주 생산으로부터 생성되는 바이오매스로부터 얻은 지방 결합제
EP2777403A1 (en) Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
WO2026096387A1 (en) Probiotics and methods to reduce weight
CN118215491A (zh) 通过植物乳杆菌进行的谷氨酸盐消耗和gaba形成
JP2004059504A (ja) 哺乳類に於けるサイトカイン類の産生異常を抑制及び／又は予防するための組成物
WO2023141408A1 (en) Beta-hydroxy beta-methylbutyrate and a citrus flavonoid for promoting muscle regeneration
HK1217082B (en) Human milk oligosaccharides to ameliorate symptoms of stress
JP2010070568A (ja) 哺乳類に於けるサイトカイン類の産生異常を抑制及び／又は予防するための組成物
DE102006001017A1 (de) Mittel zur Anwendung bei Blutzuckerstoffwechselstörungen einschließlich Diabetes